About Luwei
Shenzhen Luwei Biotechnology (Biomanifold Technology) Co., Limited develops clinically actionable immunodiagnostic and molecular diagnostic solutions for serious diseases—combining 30+ years of U.S. IVD leadership with pioneering biomarker discovery.
Featured Product
Registered non-invasive peripheral blood assay for IgA nephropathy
IgA Nephropathy ImmunoActivity Test Kit (ELISA)
Registration No.: Gan Xie Zhu Zhun 20262400131
Powered by exclusively patented molecular probe technology, NephroPlex™ detects circulating poly-IgA immune complexes in peripheral blood—a first-in-class biomarker specific to IgA nephropathy for non-invasive immune activity assessment.
Early Risk Assessment
Identifies high IgA nephropathy risk in patients with proteinuria or hematuria.
Treatment Response
Reflects immune activity improvement earlier than conventional markers such as eGFR.
Rapid Blood Assay
Non-invasive ELISA workflow requiring only a small peripheral blood sample.
Verified Performance
Clinically validated assay stability, repeatability, and diagnostic accuracy.